<!DOCTYPE html>
<html lang="en">
	<head>
		<meta charset="utf8">
		<meta name="viewport" content="width=device-width, initial-scale=1">
		<title>Risteys – ATOPIC_STRICT_REIMB – detailed case counts by code</title>
		<style type="text/css">
body {
	font-family: sans-serif;
}
.bar-plot-full {
	width: 8rem;
	border-radius: 0.1rem;
	background-color: #f2f2f2;
}
.bar-plot-full div {
	background-color: #c7c7c7;
	height: 1rem;
	border-radius: 0.1rem;
}
		</style>
	</head>
	<body>

		<table>
			<tr>
				<th>Source</th>
				<th>Code</th>
				<th>Name</th>
				<th>Case count</th>
				<th>Share of cases (%)</th>
			</tr>

			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(L200)</td>
					<td>Besnier's prurigo</td>
					<td>7443</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 77.17751970136872%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(L200)</td>
					<td>Besnier's prurigo. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>4218</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 43.737038573206135%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD8(69100)</td>
					<td>Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum</td>
					<td>1660</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 17.21277478224803%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(317)_ICD10(L20)</td>
					<td>Topical pimecrolimus and tacrolimus, Atopic dermatitis</td>
					<td>1341</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 13.905018664454582%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(6918B)</td>
					<td>Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions</td>
					<td>986</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 10.223973454997925%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(L200)</td>
					<td>Besnier's prurigo</td>
					<td>887</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.197428452924097%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(317)_ICD10(L200)</td>
					<td>Topical pimecrolimus and tacrolimus, Besnier's prurigo</td>
					<td>669</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 6.9369556200746585%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(134)_ICD10(L400)</td>
					<td>General erythroderma, Psoriasis vulgaris</td>
					<td>148</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.534632932393198%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(134)_ICD10(L26)</td>
					<td>General erythroderma, Exfoliative dermatitis</td>
					<td>76</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.7880547490667772%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(134)_ICD9(NA)</td>
					<td>General erythroderma, Name not found</td>
					<td>61</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.6325176275404396%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(134)_ICD10(L20)</td>
					<td>General erythroderma, Atopic dermatitis</td>
					<td>39</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.40439651596847787%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(134)_ICD8(NA)</td>
					<td>General erythroderma, Name not found</td>
					<td>20</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.2073828287017835%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(395)_ICD10(L20)</td>
					<td>Dupilumab, Atopic dermatitis</td>
					<td>15</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.1555371215263376%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(134)_ICD9(6961A)</td>
					<td>General erythroderma, Psoriasis and similar disorders, Other psoriasis</td>
					<td>14</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.14516798009124846%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(317)_ICD10(L209)</td>
					<td>Topical pimecrolimus and tacrolimus, Atopic dermatitis, unspecified</td>
					<td>10</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10369141435089176%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(395)_ICD10(L200)</td>
					<td>Dupilumab, Besnier's prurigo</td>
					<td>10</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.10369141435089176%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(134)_ICD10(L200)</td>
					<td>General erythroderma, Besnier's prurigo</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08295313148071339%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(134)_ICD10(NA)</td>
					<td>General erythroderma, Name not found</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.07258399004562423%"></div>
						</div>
						
					</td>
				</tr>
			

		</table>

	</body>
</html>
